Characteristic |
Participants |
Median
age
<12 months
≥12 months |
13.72 51
(51.00%) 49
(49.00%) |
Sex
Male
Female |
57
(57.00%) 43
(43.00%) |
Death |
6
(6.00%) |
Presenting
complaints
Fever
Cough
Loose stool
Vomiting
Rapid breathing
Edema |
88
(88.00%) 37
(37.00%) 41
(41.00%) 30
(30.00%) 40
(40.00%) 10
(10.00%) |
Culture
positive
Blood
Urine
CSF
Pleural fluid |
28
(28.00%) 16
(16.00%) 1/8
(12.50%) 1/1
(100%) |
Antibiotics |
Number of susceptible organism/Number tested (%) |
Total |
||||
S. aureus (N=7) |
CONS (N=8) |
Enterococcus (N=7) |
E. coli (N=3) |
Klebsiella (N=3) |
||
Amikacin |
7/7
(100%) |
7/8
(87.50%) |
5/7
(71.43%) |
2/3
(66.67%) |
2/2(100%) |
23/27 (85.19%) |
Ampicillin |
0/7
(0.00%) |
2/8
(25.00%) |
1/7
(14.29%) |
0/3
(0.00%) |
0/3(0.00%) |
3/28 (10.71%) |
Cefoperazone |
NT |
NT |
NT |
1/3
(33.33%) |
NT |
1/3
(33.33%) |
Cefotaxime |
NT |
NT |
NT |
1/3
(33.33%) |
0/3(0.00%) |
1/6 (16.67%) |
Cephalexin |
1/7
(14.29%) |
0/8
(0.00%) |
1/4
(25.00%) |
0/3
(0.00%) |
0/3(0.00%) |
2/25 (8.00%) |
Ciprofloxacin |
0/7
(0.00%) |
1/8
(12.50%) |
1/6
(16.67%) |
2/2
(100%) |
0/3(0.00%) |
4/26 (15.38%) |
Cotrimoxazole |
0/7
(0.00%) |
0/7
(0.00%) |
NT |
2/3
(66.67%) |
0/3(0.00%) |
2/20 (10.00%) |
Erythromycin |
1/5
(20.00%) |
3/8
(37.50%) |
2/6
(33.33%) |
0/1
(0.00%) |
NT |
6/20 (30.00%) |
Gentamicin |
5/7
(71.43%) |
4/8
(50.00%) |
3/7
(42.86%) |
2/3
(66.67%) |
2/3(66.67%) |
16/28 (57.14%) |
Norfloxacin |
NT |
NT |
NT |
NT |
NT |
NT |
Tetracycline |
3/7
(42.86%) |
6/6
(100%) |
4/6
(66.67%) |
2/3
(66.67%) |
2/3(66.67%) |
17/25 (68.00%) |
Antibiotics |
Susceptibility of urinary bacterial isolates |
Amikacin |
7/13 (53.85%) |
Ampicillin |
2/14 (14.29%) |
Cefoperazone |
1/10 (10.00%) |
Cefotaxime |
1/13 (7.69%) |
Cephalexin |
1/12 (8.33%) |
Ciprofloxacin |
3/14 (21.43%) |
Cotrimoxazole |
4/13 (30.77%) |
Erythromycin |
1/2 (50.00%) |
Gentamicin |
2/13 (15.38%) |
Norfloxacin |
2/3 (66.67%) |
Tetracycline |
5/14 (35.71%) |
Antibiotics |
Total |
|
Amikacin |
32/42 (76.19%) |
|
Ampicillin |
5/44 (11.36%) |
|
Cefoperazone |
2/14 (14.29%) |
|
Cefotaxime |
2/20 (10%) |
|
Cephalexin |
4/39 (10.26%) |
|
Ciprofloxacin |
7/42 (16.67%) |
|
Cotrimoxazole |
7/34 (20.59%) |
|
Erythromycin |
8/23 (34.78%) |
|
Gentamicin |
19/43 (44.19%) |
|
Norfloxacin |
2/3 (66.67%) |
|
Tetracycline |
24/42 (57.14%) |